Archive - February 2025
Biogen, Stoke Therapeutics Ink Deal to Develop Zorevunersen for Dravet Syndrome
HPM’s Larry Houck Presenting at WCF Opioid and Fentanyl Abuse Management Congress
Ask the Expert: Complying with 21 CFR 211.110
Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more
Google Launches AI Co-Scientist System
Get Up To Speed on Medicare Inflation Rebates: HPM Issues Memorandum Summarizing CMS Final Rule; HPM and Riparian to Co-Host Webinar
Novartis Commits $7.5 Million to ZERO Prostate Cancer Initiative
DSM-Firmenich CBD Product Shows Promise in OSD Forms, Study Says